Glutathione supplements are generally well tolerated at the doses used in clinical trials (250-1,000 mg/day for reduced glutathione, 500-1,000 mg/day for liposomal)
Articles on GLP-1 agonist drugs Displaying all articles A new study found people with type 2 diabetes who used drugs like Ozempic had a reduced risk of 42 health conditions or issues, but a greater risk of 19 others
18 The Need for Personalized Nutrition Making changes to address chronic disease management and weight loss requires a multi-faceted and individual approach
No pharmacological 'stack' is recommended or UK-endorsed for retatrutide outside of regulated clinical trials
Although exercise is great for improving your cardiovascular health and body composition, your diet is the biggest single factor that influences changes in your weight
When depression does surface during tirzepatide therapy, temporal association does not prove causation